ADAR1 Capital Management LLC 13D/13G Filings for Grace Therapeutics, Inc. (GRCE)

ADAR1 Capital Management LLC 13D and 13G filings for Grace Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-05-15
8:06 pm
Purchase
2026-03-3113GGRACE THERAPEUTICS, INC
GRCE
ADAR1 Capital Management LLC1,717,426
9.900%
68,635increase
(+4.16%)
Filing
2026-02-17
6:17 pm
Purchase
2025-12-3113GGRACE THERAPEUTICS, INC
GRCE
ADAR1 Capital Management LLC1,648,791
9.900%
114,537increase
(+7.47%)
Filing